SEC Form D · filed December 20, 2016
New Health Sciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Richard A. Perle · Bethesda, MDDirectorMartin A. Cannon · Bethesda, MDExec · DirectorGuy A. Cogan · Bethesda, MDDirectorStephen A. Eckert · Bethesda, MDDirectorDavid A. Herman · Bethesda, MDDirectorMichael D. Testa · Bethesda, MDDirectorMichael A. Bavonese · Bethesda, MDExecAndrew A. Dunham · Bethesda, MDExecDavid Shatz · Bluffton, SCExecDaniel T. Rewalt · Grand Cayman, Cayman IslandsDirectorBrett Topche · Philadelphia, PAExec · DirectorJulian J. Wolhardt · Grand Cayman, Cayman IslandsDirectorJohn Rubino · Bluffton, SCDirectorHaifeng D. Liu · Grand Cayman, Cayman IslandsDirectorMichael Aronson · Philadelphia, PADirectorRafael A. Cordero · Bethesda, MDExecTeng Wui Leong · Singapore, U0Exec · DirectorAaron C. Rothstein · Lihue, HIDirectorDr. Mark T. Rothstein · Athens, OHDirectorRobert A. Shen · Milpitas, CAExecSteven R. Yost · Lihue, HIDirectorAlex R. Wraight · Anahola, HIDirectorWilliam C. Miller · New York, NYDirectorRafael A. Cordero · Bethesda, MDExecAndrew A. Dunham · Bethesda, MDExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗